Imaxe de Portada

DyAb: sequence-based antibody design and property prediction in a low-data regime

Gardado en:
Publicado en:bioRxiv (Feb 2, 2025)
Autor Principal: Joshua Yao-Yu Lin
Outros autores: Hofmann, Jennifer L, Leaver-Fay, Andrew, Wei-Ching, Liang, Vasilaki, Stefania, Lee, Edith, Pinheiro, Pedro O, Tagasovska, Natasa, Kiefer, James R, Wu, Yan, Seeger, Franziska, Bonneau, Richard, Gligorijevic, Vladimir, Watkins, Andrew, Cho, Kyunghyun, Frey, Nathan C
Publicado:
Cold Spring Harbor Laboratory Press
Materias:
Protein folding
Predictions
Drug development
Amino acid sequence
Protein engineering
Proteins
Acceso en liña:Citation/Abstract
Full Text - PDF
Full text outside of ProQuest
Etiquetas: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Resumo:Protein therapeutic design and property prediction are frequently hampered by data scarcity. Here we propose a new model, DyAb, that addresses these issues by leveraging a pair-wise representation to predict differences in protein properties, rather than absolute values. DyAb is built on top of a pre-trained protein language model and achieves a Spearman rank correlation of up to 0.85 on binding affinity prediction across molecules targeting three different antigens (EGFR, IL-6, and an internal target), given as few as 100 training data. We employ DyAb in two design contexts: as a ranking model to score combinations of known mutations, and combined with a genetic algorithm to generate new sequences. Our method consistently generates novel antibody candidates with high binding rates, including designs that improve on the binding affinity of the lead molecule by more than ten-fold. DyAb represents a powerful tool for engineering therapeutic protein properties in low data regimes common in early-stage drug development.Competing Interest StatementThe authors have declared no competing interest.
ISSN:2692-8205
DOI:10.1101/2025.01.28.635353
Fonte:Biological Science Database